DE69636923D1 - Katalytischer antikörper gegen aldolase - Google Patents

Katalytischer antikörper gegen aldolase

Info

Publication number
DE69636923D1
DE69636923D1 DE69636923T DE69636923T DE69636923D1 DE 69636923 D1 DE69636923 D1 DE 69636923D1 DE 69636923 T DE69636923 T DE 69636923T DE 69636923 T DE69636923 T DE 69636923T DE 69636923 D1 DE69636923 D1 DE 69636923D1
Authority
DE
Germany
Prior art keywords
antibody against
catalytic
catalytic antibody
antibody
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69636923T
Other languages
English (en)
Other versions
DE69636923T2 (de
Inventor
Carlos F Barbas
Richard A Lerner
Juergen Wagner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Publication of DE69636923D1 publication Critical patent/DE69636923D1/de
Application granted granted Critical
Publication of DE69636923T2 publication Critical patent/DE69636923T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/24—Preparation of oxygen-containing organic compounds containing a carbonyl group
    • C12P7/26—Ketones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0002—Antibodies with enzymatic activity, e.g. abzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/901—Antibodies with enzymatic activity; e.g. abzymes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DE69636923T 1995-12-15 1996-12-16 Katalytischer antikörper gegen aldolase Expired - Lifetime DE69636923T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/573,415 US5733757A (en) 1995-12-15 1995-12-15 Aldolase catalytic antibody
US573415 1995-12-15
PCT/US1996/020052 WO1997021803A1 (en) 1995-12-15 1996-12-16 Aldolase catalytic antibody

Publications (2)

Publication Number Publication Date
DE69636923D1 true DE69636923D1 (de) 2007-04-05
DE69636923T2 DE69636923T2 (de) 2007-11-08

Family

ID=24291910

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69636923T Expired - Lifetime DE69636923T2 (de) 1995-12-15 1996-12-16 Katalytischer antikörper gegen aldolase

Country Status (12)

Country Link
US (3) US5733757A (de)
EP (1) EP0870014B9 (de)
JP (1) JP3996642B2 (de)
AT (1) ATE354644T1 (de)
AU (1) AU729055B2 (de)
CA (1) CA2239167C (de)
DE (1) DE69636923T2 (de)
DK (1) DK0870014T3 (de)
ES (1) ES2283009T3 (de)
PT (1) PT870014E (de)
SI (1) SI0870014T1 (de)
WO (1) WO1997021803A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999031263A1 (en) * 1997-12-18 1999-06-24 The Scripps Research Institute Aldol condensations by catalytic antibodies
US6326176B1 (en) * 1997-12-18 2001-12-04 The Scripps Research Institute Aldol condensations by catalytic antibodies
US6440710B1 (en) 1998-12-10 2002-08-27 The Scripps Research Institute Antibody-catalyzed deuteration, tritiation, dedeuteration or detritiation of carbonyl compounds
US6294374B1 (en) * 1999-10-08 2001-09-25 The Scripps Research Institute Use of catalytic antibodies for synthesizing epothilone
US20040048312A1 (en) * 2002-04-12 2004-03-11 Ronghao Li Antibodies that bind to integrin alpha-v-beta-6 and methods of use thereof
AU2006235781B2 (en) * 2004-04-27 2008-04-03 Teddy Yeung Man Lo LED illuminated glow stick
JP5167473B2 (ja) * 2005-03-03 2013-03-21 コヴェックス・テクノロジーズ・アイルランド・リミテッド 抗血管新生化合物
AU2007318912B2 (en) 2006-11-10 2011-03-03 Covx Technologies Ireland Limited Anti-angiogenic compounds
US20090098130A1 (en) * 2007-01-05 2009-04-16 Bradshaw Curt W Glucagon-like protein-1 receptor (glp-1r) agonist compounds
CA3128656A1 (en) 2007-08-22 2009-02-26 The Regents Of The University Of California Activatable binding polypeptides and methods of identification and use thereof
US8637435B2 (en) * 2007-11-16 2014-01-28 Merck Sharp & Dohme Corp. Eukaryotic cell display systems
US8340951B2 (en) 2007-12-13 2012-12-25 University Of Washington Synthetic enzymes derived from computational design
CA2715212A1 (en) 2008-03-03 2009-09-11 Glycofi, Inc. Surface display of recombinant proteins in lower eukaryotes
US8293714B2 (en) 2008-05-05 2012-10-23 Covx Technology Ireland, Ltd. Anti-angiogenic compounds
US8067339B2 (en) 2008-07-09 2011-11-29 Merck Sharp & Dohme Corp. Surface display of whole antibodies in eukaryotes
JP5851842B2 (ja) 2009-01-12 2016-02-03 サイトムエックス セラピューティクス, インク.CytomX Therapeutics, Inc. 改変した抗体組成物、それを作製および使用する方法
AU2010215761B2 (en) * 2009-02-23 2017-04-06 Cytomx Therapeutics, Inc Proproteins and methods of use thereof
CN102333872B (zh) 2009-02-25 2014-07-09 默沙东公司 在糖工程化的酵母巴斯德毕赤酵母中对半乳糖同化途径的代谢工程化
US20120148586A1 (en) 2009-08-27 2012-06-14 Joyce Ching Tsu Chou Glucagon-like protein-1 receptor (glp-1r) agonists for treating autoimmune disorders
AU2011220878A1 (en) 2010-02-24 2012-08-23 Merck Sharp & Dohme Corp. Method for increasing N-glycosylation site occupancy on therapeutic glycoproteins produced in Pichia pastoris
JP5913307B2 (ja) 2010-07-12 2016-04-27 コヴェックス・テクノロジーズ・アイルランド・リミテッド 多機能性抗体複合体
WO2012009705A1 (en) 2010-07-15 2012-01-19 Zyngenia, Inc. Ang-2 binding complexes and uses thereof
US9688735B2 (en) 2010-08-20 2017-06-27 Wyeth Llc Designer osteogenic proteins
EP2949338B1 (de) 2010-08-20 2017-10-25 Wyeth LLC Osteogene designerproteine
JP2014500248A (ja) 2010-11-05 2014-01-09 コヴェックス・テクノロジーズ・アイルランド・リミテッド 抗糖尿病化合物
CN106432506A (zh) 2011-05-24 2017-02-22 泽恩格尼亚股份有限公司 多价和单价多特异性复合物及其用途
CA2860109C (en) 2011-12-20 2016-08-09 Javier Magano Improved processes for preparing peptide conjugates and linkers
CN104066438B (zh) 2011-12-22 2015-09-23 辉瑞公司 抗糖尿病化合物
EP2810069A4 (de) 2012-02-03 2015-08-12 Univ Alberta Verfahren zur quantifizierung von peptidderivatbibliotheken mittels phagenanzeige
EP2968541A4 (de) 2013-03-15 2017-02-08 Zyngenia, Inc. Multivalente und monovalente multispezifische komplexe und deren verwendungen
WO2020076849A1 (en) * 2018-10-11 2020-04-16 The Scripps Research Institute Antibody compounds with reactive arginine and related antibody drug conjugates

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571681A (en) * 1994-03-10 1996-11-05 The Scripps Research Institute Chemical event selection by suicide substrate conjugates

Also Published As

Publication number Publication date
WO1997021803A1 (en) 1997-06-19
JP3996642B2 (ja) 2007-10-24
EP0870014B1 (de) 2007-02-21
CA2239167A1 (en) 1997-06-19
US5733757A (en) 1998-03-31
PT870014E (pt) 2007-05-31
EP0870014B9 (de) 2007-10-10
AU729055B2 (en) 2001-01-25
ES2283009T3 (es) 2007-10-16
DE69636923T2 (de) 2007-11-08
EP0870014A4 (de) 2002-03-13
US5985626A (en) 1999-11-16
JPH11510063A (ja) 1999-09-07
ATE354644T1 (de) 2007-03-15
US6368839B1 (en) 2002-04-09
EP0870014A1 (de) 1998-10-14
CA2239167C (en) 2009-09-22
AU1292397A (en) 1997-07-03
SI0870014T1 (sl) 2007-08-31
DK0870014T3 (da) 2007-06-11

Similar Documents

Publication Publication Date Title
DE69636923D1 (de) Katalytischer antikörper gegen aldolase
DK0404097T3 (de)
IL132380A0 (en) Compositions comprising conjugates of stable active human ob protein with antibody fc chain and methods
NL300411I1 (nl) Werkwijze voor het met gebruikmaking van nieuwe cyanilerende reagentia
ES2106195T3 (es) Anticuerpo igg aglicosilado anti cd3.
AU563356B2 (en) Conjugate of enzyme and antibody
MY104946A (en) Antigen antibody conjugate.
NO981745L (no) Monoklonalt antistoff BR110 og anvendelse av dette
ATE187494T1 (de) Multivalente einkettige antikörper
EP1181938A3 (de) Rapamycin - Konjugate und Antikörper
WO2000073796A3 (de) Ligand-anker-konjugate zur generierung einer biosensor-schicht
AU5799898A (en) Method for improving the recovery of troponin i and t
CA2348026A1 (en) Antibodies against semp1, methods for their production and uses thereof
DE69412815T2 (de) Künstliche rezeptoren, antikörper und enzyme
NO20062410L (no) Malretting av ERB-antigener
WO1995007466A3 (en) Biotin-analog conjugated antibodies for positive cell selection and release
SE8800886D0 (sv) Immunoglobulin conjugates
EP0601318A3 (de) Verfahren zur Herstellung von Konjugaten aus einem spezifischen Bindungspartner und einem kohlenhydrathaltigen Protein.
DE3850993T2 (de) Monoklonaler Antikörper spezifisch gegen humane Pankreas-Phospholipase-A2.
AU2440188A (en) Immunoassays using antigens produced in heterologous organisms
AU2169797A (en) Improved production of antibodies through the use of antigen antibody complexes
CA2559998A1 (en) Rapamycin conjugates and antibodies
DE59913949D1 (de) Humane monoklonale antikörper gegen inselzellantigen ia-2

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: GROSSE, SCHUMACHER, KNAUER, VON HIRSCHHAUSEN, 8033